Hepatic monooxygenase activities in subjects with a genetic defect in drug oxidation
- 1 September 1983
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 85 (3), 682-692
- https://doi.org/10.1016/0016-5085(83)90026-4
Abstract
No abstract availableThis publication has 44 references indexed in Scilit:
- Oxidation Phenotype — A Major Determinant of Metoprolol Metabolism and ResponseNew England Journal of Medicine, 1982
- HIGH PLASMA CONCENTRATIONS OF β-RECEPTOR BLOCKING DRUGS AND DEFICIENT DEBRISOQUINE HYDROXYLATIONThe Lancet, 1982
- Defective Oxidation of DrugsClinical Pharmacokinetics, 1982
- Cytochrome P-450 Monooxygenase Activities in Human and Rat Liver MicrosomesEuropean Journal of Biochemistry, 1981
- Isolation and characterization of rough endoplasmic reticulum associated with mitochondria from normal rat liverBiochimica et Biophysica Acta (BBA) - Biomembranes, 1981
- Some observations on the oxidation phenotype status of Nigerian patients presenting with cancerCancer Letters, 1981
- Ethnic difference in drug metabolism: debrisoquine 4-hydroxylation in Caucasians and OrientalsCanadian Journal of Physiology and Pharmacology, 1980
- The polymorphic 4-hydroxylation of debrisoquine in a Saudi arab populationXenobiotica, 1980
- A study of the debrisoquine hydroxylation polymorphism in a Nigerian populationXenobiotica, 1980
- A Population and Familial Study of the Defective Alicyclic Hydroxylation of Debrisoquine among EgyptiansXenobiotica, 1979